News tagged with blood cancers
Related topics: cancer cells , cancer , stem cells , bone marrow , blood cells
Genotype predicts treatment related mortality (TRM) in African-American and Asian pediatric AML patients
New research suggests that the presence of a specific genetic marker, known as WT1 SNP rs16754, may be associated with reduced toxicity from chemotherapy in African-American and Asian children with acute myeloid leukemia ...
Cancer
Dec 09, 2012 |
not rated yet |
0
ATRA and arsenic trioxide versus ATRA and idarubicin for newly diagnosed, non high-risk acute promyelocytic
New research demonstrates the efficacy of the first curative treatment for acute promyelocytic leukemia (APL) that does not include chemotherapy, marking an important step toward front-line use of targeted therapies for acute ...
Cancer
Dec 09, 2012 |
not rated yet |
0
Avastin won't extend breast cancer survival: study
(HealthDay)—The drug Avastin (bevacizumab), when added to chemotherapy, does not improve disease-free survival in patients with triple-negative breast cancer any better than chemo alone, new research finds.
Medications
Dec 07, 2012 |
not rated yet |
0
|
Immune system kill switch could be target for chemotherapy and infection recovery
Researchers have discovered an immune system 'kill switch' that destroys blood stem cells when the body is under severe stress, such as that induced by chemotherapy and systemic infections.
Immunology
Dec 06, 2012 |
5 / 5 (2) |
0
|
Cocktail boosts immune cells in fighting cancer
Natural killer cells, as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer ...
Cancer
Dec 06, 2012 |
not rated yet |
0
|
Breast cancer drug could hold the key to fighting other tumours
New research out of the United Kingdom is showing that a common drug used in the fight against breast cancer could also be employed in the fight against other tumours. The drug in question is geldanamycin, ...
Cancer
Dec 05, 2012 |
5 / 5 (1) |
0
Neuroblastoma patients with ARID1A and ARID1B mutations have more aggressive disease
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A ...
Genetics
Dec 02, 2012 |
not rated yet |
0
|
Cometriq approved for rare thyroid cancer
(HealthDay)—Cometriq (cabozantinib) has been approved by the U.S. Food and Drug Administration to treat modullary thyroid cancer that has spread to other parts of the body, the agency said Thursday.
Medications
Nov 29, 2012 |
not rated yet |
0
Mediation with art therapy can change your brain and lower anxiety
Cancer and stress go hand-in-hand, and high stress levels can lead to poorer health outcomes in cancer patients. The Jefferson-Myrna Brind Center of Integrative Medicine combined creative art therapy with a Mindfulness-based ...
Psychology & Psychiatry
Nov 29, 2012 |
5 / 5 (3) |
0
Diabetics with cancer dangerously ignore blood sugar
When people with Type 2 diabetes are diagnosed with cancer—a disease for which they are at higher risk—they ignore their diabetes care to focus on cancer treatment, according to new Northwestern Medicine® research. But ...
Diabetes
Nov 29, 2012 |
not rated yet |
0
Scientists pair blood test and gene sequencing to detect cancer
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients ...
Cancer
Nov 28, 2012 |
not rated yet |
0
|
New study points to potential new therapies for cancer and other diseases
Researchers at The Scripps Research Institute (TRSI) are fueling the future of cancer treatment by improving a powerful tool in disease defense: the body's immune system. By revealing a novel but widespread cell signaling ...
Medical research
Nov 27, 2012 |
4.7 / 5 (3) |
0
Researchers link new molecular culprit to breast cancer progression
(Phys.org)—Johns Hopkins researchers have uncovered a protein "partner" commonly used by breast cancer cells to unlock genes needed for spreading the disease around the body. A report on the discovery, published November ...
Cancer
Nov 25, 2012 |
2.5 / 5 (2) |
0
|
Boosting immune responses against leukaemia
(Medical Xpress)—In the first of its kind, a translational study undertaken at the Malaghan Institute of Medical Research has revealed that boosting the activity of a rare type of immune cell could be an ...
Cancer
Nov 21, 2012 |
5 / 5 (1) |
0
Groundbreaking study that may change transplant practices
Researchers from John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's 50 best cancer centers, played an important role in a study published in the New England Journal of Medicine on Oct ...
Medical research
Nov 20, 2012 |
not rated yet |
0
